HCAT Health Catalyst Forecast, Technical & Fundamental Analysis

Aroon Indicator for HCAT shows an upward move is likely

HCAT's Aroon Indicator triggered a bullish signal on September 25, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 109 similar instances where the Aroon Indicator showed a similar pattern. In 92 of the 109 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 84%.

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HCAT's RSI Oscillator exited the oversold zone, 32 of 47 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.

The Momentum Indicator moved above the 0 level on September 24, 2026. You may want to consider a long position or call options on HCAT as a result. In 62 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.

The Moving Average Convergence Divergence (MACD) for HCAT just turned positive on September 01, 2026. Looking at past instances where HCAT's MACD turned positive, the stock continued to rise in 37 of 48 cases over the following month. The odds of a continued upward trend are 77%.

Following a +5.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCAT advanced for three days, in 178 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 52 cases where HCAT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 87%.

HCAT moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.

HCAT broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.299) is normal, around the industry mean (7.427). HCAT has a moderately low P/E Ratio (0.000) as compared to the industry average of (46.498). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.129). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (0.429) is also within normal values, averaging (6.065).

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. HCAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.